Screening of malnutrition risk versus indicators of nutritional status and systemic inflammatory response in newly diagnosed lung cancer patients;Screening rizika malnutrice versus ukazatelé nutriční ho stavu a systémové zánětlivé odpovědi u pacientů s nově diagnostikovaným karcinomem plic

Klinicka Onkologie

Volumn 27, Issue 4, 2014, Pages 261-268

  Illa, P ^a   Tomiskova M ^a   Skrickova J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Acute phase response; Lung cancer; Nutritional risk; Nutritional status

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ALBUMINOID;

ACUTE PHASE RESPONSE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER THERAPY; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; HUMAN; LUNG CANCER; MALNUTRITION; MORBIDITY; NUTRITIONAL RISK SCREENING; NUTRITIONAL STATUS; PROTEIN CALORIE MALNUTRITION; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BODY MASS; BODY WEIGHT; DISEASE ASSOCIATION; MAJOR CLINICAL STUDY; SCREENING TEST; BLOOD; COMPLICATION; LUNG TUMOR; METABOLISM;

ALBUMINS; C-REACTIVE PROTEIN; HUMANS; LUNG NEOPLASMS; MALNUTRITION; NUTRITIONAL STATUS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84907474377     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: 10.14735/amko2014261     Document Type: Article

References (30)

1. Dewys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69(4): 491-497.
2. Chute CG, Greenberg ER, Baron J et al. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer 1985; 56(8): 2107-2111.
3. Ross PJ, Ashley S, Norton A et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90(10): 1905-1911.
4. Buccheri G, Ferrigno D. Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 2001; 34(3): 433-440.
5. Jeremic B, Milície B, Dagovic A et al. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol 2003; 129(2): 114-122.
6. van Eys J. Effect of nutritional status on response to therapy. Cancer Res 1982; 42 (Suppl): 747-753.
7. Simons JP, Schols AM, Buurman WA et al. Weight loss and low body cell mass in males with lung cancer, relationship with systemic inflammation, acute phase response, resting energy expenditure and ca-tabolic and anabolic hormones. Clin Sci 1999; 97(2): 215-223.
8. Martin F, Santolaria F, Batista N et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 1999; 11(1): 80-86.
9. O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 2000; 37(1): 36-40.
10. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002; 2(11): 862-871.
11. Forrest LM, McMillan DC, McArdle CS et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 2004; 90(9): 1704-1705.
12. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 2008; 67(3): 257-262. doi: 10.1017/S0029665108007131.
13. Murry D, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of antineoplastic agents. Int J Cancer 1998;11:48-51.
14. Watanabe H, Yamamoto N, Tamura T et al. Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancer. Jpn J Clin Oncol 2003; 33(12): 626-630.
15. Kondrup J, Rasmussen HH, Hamberg O et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22(3): 321-336.
16. Kondrup J, Allison SP, Elia M et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003; 22(4): 415-421.
17. Tomíška M. Nutričnl rizikový screening v onkologické ambulanci. Medical Tribune 2008; 1:15.
18. Arrieta O, Michel Ortega RM, Villanueva-Rodrlguez G et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010; 50(10). doi: 10.1186/1471-2407-10-50.
19. Gioulbasanis I., Baracos VE, Giannousi Z et al. Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Ann Oncol 2011; 22(4): 835-841. doi: 10.1093/annonc/mdq440.
20. Bozzetti F, Mariani L, Lo Vullo S et al. The nutritional risk in oncology: a study of 1453 cancer outpatients. Support Care Cancer 2012; 20(8): 1919-1928. doi: 10.1007/s00520-012-1387-x
21. Orreval Y, Tishelman C, Permert J et al. Nutritional support and risk status among cancer patients in palliative home care service. Support Care Cancer 2009; 17(2): 153-161.doi: 10.1007/S00520-008-0467-4.
22. Deng H, Seidel K, Bruemmer B et al. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Trasnplant 1995; 15(3): 461-468.
23. Tomfšková M, Tomlška M, Hla P et al. Nutritional risk screening predicts tumor response in lung cancer patients. J Thor Oncol 2009; 4(9): 435-436.
24. Lochs H, Allison SP, Meier R et al. Introductory to the ESPEN Guidelines on Enteral Nutrition:terminology, definitions and general topics. Clin Nutr 2006; 25(2): 180-186.
25. Segura A, Pardo J, Jara C et al. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advance or metastatic cancer. Clin Nutr 2005; 24(5): 801-814.
26. Forrest LM, McMillan DC, McArdle CS et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003; 89(6): 1028-1030.
27. Forrest LM, McMillan DC, McArdle CS et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 2004; 90(9): 1704-1706.
28. Doweiko IP, Nompleggi DJ.The role of albumin in human physiology and pathophysiology. Part III: albumin and disease states. J Parent Enteral Nutr 1991; 15(4): 476-482.
29. Tomíška M. Syndrom nádorové anorexie a kachexie. Onkologie 2008,2(3): 174-178.
30. Scon HR, McMillan DC, Forrest LM et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002; 87(3): 264-267.